RxDoctor Payments Data

Linda Wong, MD

Dermatology · Baldwin Park, CANPI 1689741506

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,110 of the $1,248 with a category attached, or 88.9%. 16 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 25.2% of the total. 2025 is the largest year on record at $602, 8.8 times the $68 reported in 2019. That places this record below the midpoint for dermatology clinicians in CA, where the typical reported total is $1,655.

$1,248in general payments, 2019–2025

Across 24 payments — averaging $52.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$314
  • Sun Pharmaceutical Industries Inc.$171
  • AbbVie$168
  • Pfizer$92
  • AstraZeneca$89
  • Incyte Corporation$77
  • plus $337 from 10 others

What the payments were for

  • Food & beverage$1,11089%
  • Education$13811%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,248 in reported general payments places this provider in the 45th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024
$21,186
Medicare patients
85
Services billed
254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinonide12$310
Ketoconazole17$221
Triamcinolone Acetonide11$136

Paid to pharmacies, not to this prescriber.

Other dermatology in Baldwin Park

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →